LivaNova PLC
NASDAQ:LIVNMedical - Devices
+$0.76 today
- Market cap
- $5.21B
- Beta
- 0.88
- P/E (TTM)
- 40.5
- EPS (TTM)
- $1.96
Volume 1.32M
Average 0.79M
LIVN Long-term Debt
Borrowings due after more than one year.
LivaNova PLCNASDAQ: LIVN
Long-term Debt · Q3 FY2026 · quarter ended Sep 2026
Long-term debt falls 15.4% from a year ago
Long-term debt stood at $295.2M at the end of Q3 FY2026, down 15.4% from a year earlier and up 1.8% from the prior quarter. Over 3 fiscal years it compounded at -8.8% a year.
Context
- Long-term debt amounted to 10.9% of total assets at the end of Q3 FY2026, down 2.8 pp from a year earlier.
- Long-term debt increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether long-term debt keeps falling in the next quarterly balance sheet after a -15.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Debt history
USD · from the balance sheet
- Latest · FY2025
- 393.5M USD
- Year-over-year change
- -28.4%
- 4-year CAGR
- +151.4%
| Period | Period end | Long-term Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 393.5M | -28.4% |
| FY2024 | 2024-12-31 | 549.62M | -3.3% |
| FY2023 | 2023-12-31 | 568.54M | +9.7% |
| FY2022 | 2022-12-31 | 518.07M | +5160.1% |
| FY2021 | 2021-12-31 | 9.85M | — |
Long-term Debt vs competitors
How LIVN compares with its peers on the latest reported figures
- LIVN's Sep 2026 long-term debt of $295.2M is the 6th highest of the 10 companies compared; the peer median is $399.42M.
- Its year-over-year change of -15.4% is the 8th highest of 9, against a peer median of -0.6%.
- Long-term debt amounts to 10.9% of total assets for LIVN, versus a peer median of 27.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jul 2026 | $25.62B | -2.0% | +2.5% | 27.5% | |
| Jun 2026 | $10.79B | -1.7% | +8.7% | 23.9% | |
| Jun 2026 | $1.17B | +27.0% | +17.4% | 49.4% | |
| Jun 2026 | $598.7M | +0.1% | +0.1% | 4.3% | |
| Jun 2026 | $399.42M | -39.3% | -34.7% | 4.5% | |
| Sep 2026 | $295.2M | -15.4% | -8.8% | 10.9% | |
| Mar 2026 | $61.3M | +10.8% | +42.3% | 48.9% | |
| Mar 2026 | $59.03M | +19.7% | +95.2% | 59.2% | |
| Mar 2026 | $59.02M | -1.3% | +3.6% | 59.7% | |
| Jun 2026 | $0 | — | — | 0.0% | |
MOBIMobia Medical, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding LIVN) | $399.42M | -0.6% | +6.2% | 27.5% | |
Competitors are the stored peer set for LIVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 207.99M | 214.17M | 266.5M | 428.86M | 635.6M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 222.98M | 214.82M | 215.07M | 223.7M | 216M |
| Inventory | 105.84M | 129.38M | 147.89M | 147.57M | 164.7M |
| Other Current Assets | 104.75M | 296.06M | 311.37M | 327.06M | 85.3M |
| Total Current Assets | 679.18M | 886.14M | 988.16M | 1.13B | 1.1B |
| Property, Plant & Equipment (Net) | 190.67M | 183.02M | 205.03M | 217.1M | 298.1M |
| Goodwill | 899.53M | 768.79M | 782.94M | 750.01M | 792.8M |
| Intangible Assets | 399.68M | 368.56M | 261.18M | 237.29M | 230M |
| Long-term Investments | 16.6M | 16.27M | 22.84M | 25.08M | 20.3M |
| Tax Assets | 2.2M | 1.38M | 118.86M | 111.86M | 111M |
| Other Non-current Assets | 13.1M | 70.62M | 50.56M | 37.87M | 52.3M |
| Total Non-current Assets | 1.52B | 1.41B | 1.44B | 1.38B | 1.5B |
| Total Assets | 2.2B | 2.29B | 2.43B | 2.51B | 2.61B |
| Account Payables | 68M | 74.31M | 80.85M | 69.73M | 97.2M |
| Short-term Debt | 229.67M | 23.43M | 18.11M | 78M | 31.5M |
| Tax Payables | 15.14M | 16.51M | 23.34M | 32.46M | 33.1M |
| Deferred Revenue | 8.42M | 10.23M | 10.73M | 10.85M | 0 |
| Other Current Liabilities | 297.76M | 109.23M | 98.97M | 51.2M | 553.4M |
| Total Current Liabilities | 696.97M | 297.4M | 334.98M | 392.13M | 808.1M |
| Long-term Debt | 9.85M | 518.07M | 568.54M | 549.62M | 393.5M |
| Deferred Tax Liabilities | 7.73M | 8.52M | 11.57M | 10.92M | 9.6M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 155.84M | 233.62M | 191.45M | 193.36M | 146.6M |
| Total Non-current Liabilities | 209.34M | 789.75M | 816.95M | 794.01M | 598M |
| Total Liabilities | 906.31M | 1.09B | 1.15B | 1.19B | 1.41B |
| Common Stock | 82.3M | 82.42M | 82.53M | 83.16M | 0 |
| Retained Earnings | (897.78M) | (984.03M) | (966.48M) | (903.25M) | 0 |
| Accumulated OCI | (7.18M) | (48.12M) | (27.88M) | (80.17M) | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 1.2B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.29B | 1.21B | 1.28B | 1.32B | 1.2B |
| Total Debt | 286.7M | 580.43M | 640.4M | 676.77M | 473.3M |
| Net Debt | 78.71M | 366.26M | 373.9M | 247.92M | (162.3M) |
LivaNova PLC
NASDAQ:LIVN
Intrinsic Alpha fair value
Locked
Current Price
$94.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.